A Case of Acquired Haemophilia A in a Patient with Chronic Myelomonocytic Leukaemia

Table 1

Clinical data on admission.

		Normal range
White blood cell	13.6 × 10^9/L	(3.5–9.7)
Neutrophil	7.6 (56.1%) × 10^9/L	(38–74%)
Eosinophil	0.16 (1.2%) × 10^9/L	(0–8.5%)
Basophil	0.03 (0.2%) × 10^9/L	(0–2.5%)
Monocyte	4.6 (33.6%) × 10^9/L	(2–10%)
Lymphocyte	1.2 (8.9%) × 10^9/L	(16–50%)
Red blood cell 312	× 10^4/μL	(400–550)
Haemoglobin	8.8 g/dL	(13.2–17.2)
Haematocrit	28.1%	(40–52)
MCV	90.1%	(85–103)
Platelet	258 × 10^9/L	(140–370)
AST	18 IU/L	(13–33)
ALT	12 IU/L	(8–42)
CK	38 IU/L	(62–287)
LD	270 IU/L	(119–229)
Total bilirubin	0.93 mg/dL	(0.2–1.3)
BUN	15.0 mg/dL	(8–20)
Creatinine	0.77 mg/dL	(0.6–1.1)
Total protein	6.4 g/dL	(6.7–8.3)
Albumin	3.7 g/dL	(3.9–4.9)
CRP	2.37 mg/dL	(<0.3)
PT	13.7 s	(10.5–14)
APTT	85.8 s	(24–39)
Fibrinogen	458 mg/dL	(200–400)
FDP	5.6 μg/mL	(<5)
Anticardiolipin β2GPI	<1.2 U/mL	(<3.5)
Anticardiolipin antibody	<8 U/mL	(<10)
Lupus anticoagulant	1.06 ratio	(<1.3)
Factor VIII activity	<1%	(60–150)
Factor IX activity	34%	(70–130)
Factor XI activity	20%	(75–145)
Factor XII activity	19%	(50–150)
Factor VIII inhibitor	166 BU/mL	(<1)
Factor IX inhibitor	1 BU/mL	(<1)
vWF activity	>200%	(60–170)